Related Experiment Video
Updated: Mar 2, 2026

04:20
Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
Published on: March 28, 2025
646
Is there a "July effect" in pediatric neurosurgery?
Yimo Lin1, Rory R Mayer2,3, Terence Verla2,3
1Department of Neurosurgery, Oregon Health and Sciences University, Portland, OR, USA.
Summary
The "July effect" in pediatric neurosurgery showed no significant increase in most patient complications during the first academic quarter. However, some specific issues like pneumonia and re-operations were more frequent in the first quarter.
Area of Science:
- Neurosurgery
- Patient Safety
- Healthcare Quality
Background:
- The
Purpose of the Study:
- To investigate the association between the start of the academic year and patient outcomes in pediatric neurosurgery.
- To compare complication rates in pediatric neurosurgical procedures between the first and last academic quarters.
Main Methods:
- Utilized data from the National Surgical Quality Improvement Program-Pediatrics (NSQIP-P) and the Kids' Inpatient Database (KID) for 2012.
- Analyzed 30-day and in-hospital complication events after pediatric neurosurgical procedures.
- Employed descriptive and analytic statistical methods to assess seasonal variations.
Main Results:
- No significant differences in most complication rates (e.g., wound infections, nerve injury, death) between the first and last academic quarters.
- The first quarter showed a higher incidence of pneumonia and unplanned re-operations in the NSQIP-P dataset.
- No significant differences in pneumonia or sepsis rates were found in the KID dataset.
Conclusions:
- The majority of patient morbidity and mortality events did not differ significantly between the first and last academic quarters.
- While most outcomes were similar, specific complications like pneumonia warrant further attention during the initial training period.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
293
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
411
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
411
Pharmacokinetics in Pediatric Patients: Drug Distribution
388
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388

